SIRT1 inhibition impaired proliferation of HCC cells in-vitro and cambinol treatment resulted in an overall lower tumor burden in-vivo in an orthotopic xenograft model [258] (Table 2). Here, SIRT1 is linked to hepatocellular carcinoma.